Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd., explained in plain language.
-
New hope for lung cancer patients after first treatment fails
Disease control OngoingThis study is testing whether a new drug called SHR-A2009 works better than standard chemotherapy for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation) and has stopped responding to their initial targeted therapy. About 500 adults …
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New drug cocktail aims to shrink tough stomach and esophageal tumors
Disease control OngoingThis study is testing a new three-drug combination for people with advanced stomach or esophageal cancer who haven't had prior treatment. It combines an experimental immunotherapy drug (SHR-8068) with an approved immunotherapy (adebrelimab) and standard chemotherapy. The main goa…
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC